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Summary The cytophotometric DNA content and the argyrophilic nucleolar organiser regions (AgNORs) of
biopsy specimens taken before undergoing any treatment were examined in 91 surgically treated cesophageal
carcinoma cases. There was a significant linear dependence between the mean DNA content and the number
of AgNOR per nucleus (AgNOR number) (r = 0.615, P<0.001). The DNA distribution pattern and the range
of the AgNOR number also showed a significant correlation (P<0.01). Twenty three of 28 cases with a low
AgNOR number (<4) were then determined to have a diploid pattern (type II), while 17 out of 22 cases with
a high AgNOR number ( > 6) had high ploidy values (type IV). The patients with a type II DNA distribution
pattern and a low AgNOR number thus showed a good post-operative course with a 5 year survival rate of
55.2%, whereas no patients survived over 4 years among the 17 cases with both a type IV DNA pattern and a
high AgNOR number (P<0.001). These data thus demonstrate the close relationship between cytophotomet-
ric DNA content and AgNOR number and suggest that the combined detection of these two parameters, using
biopsy specimens, should be of benefit in making an accurate preoperative evaluation of prognosis for patients
with cesophageal carcinoma.
The cytophotometric analysis of DNA content is generally
accepted as one of the parameters for identifying malignant
potentiality in carcinomas of various organs, such as the
stomach (Korenaga et al., 1988), colon (Wolley et al., 1982),
and lung (Blondal et al., 1981). Aneuploid tumours pro-
liferate rapidly and have a high incidence of either nodal
involvement or distant metastasis, leading to a poor prog-
nosis. As for aesophageal carcinoma, our multivariate analysis
revealed that the DNA distribution pattern is one of the
most important prognostic factors (Matsuura et al., 1986;
Sugimachi et al., 1988).
On the other hand, the nucleolar organiser regions (NORs)
are loop DNA (rDNA) encoded for rRNA production
(Fakan & Hernandez-Verdan, 1986) and the development of
a one-step silver colloid staining method makes it easy to
visualise the proteins associated with the NORs (Howell &
Black, 1980; Ploton et al., 1986). These so-called AgNORs
(argyrophilic nucleolar organiser regions) have been studied
in the malignant tumours of various organs. As a result, it
has been suggested that the number of AgNOR per nucleus
(AgNOR number) correlates with the cellular mitotic activity
(Kakeji et al., 1991; Hall et al., 1988; Tanaka et al., 1989;
Egan et al., 1988a), and that, in addition, it might be a
diagnostic parameter of the malignant grade of lesions
(Suarez et al., 1989; Abe et al., 1991) and a predictor of
lymph node metastasis (Kakeji et al., 1991) or a patient's
prognosis (Egan et al., 1988b; Ruschoff et al., 1990; Offner et
al., 1990). In patients with cesophageal carcinoma, we recently
reported that the AgNOR number was also a significant
prognostic factor independent from other pathological fac-
tors, using a multivariate analysis (Morita et al., 1991).
The relation between the AgNOR number and the results
of a cytophotometric DNA analysis has never been
previously examined in any malignancies. It was therefore
thought to be of interest to evaluate both the DNA content
and the AgNOR number together as predictors of the malig-
nant potential of tumours. In this report, we thus examined
the DNA content and the AgNOR number of cesophageal
carcinoma in 91 surgically treated cases, using biopsy speci-
mens, while the biologic roles and the prognostic values were
also discussed.
Materials and methods
Clinical material
This study included 91 Japanese patients with squamous cell
carcinoma of the thoracic cesophagus. Of these patients, 77
were men and 14 were women. All of these patients under-
went cesophagectomy and reconstruction with a gastric tube in
our department between 1974 and 1989. There was no
evidence of any microscopic metastasis to other organs.
Pathological evaluations were based on the rules estab-
lished by the Japanese Society for CEsophageal disease
(Nakayama, 1976). Measurements of the cell nuclear DNA
content and AgNOR number were performed on the same
biopsy specimens obtained using endoscopy before undergo-
ing any preoperative treatment. Each analysis was done by
different investigators (DNA; by S.T. and S.O., AgNOR; by
M.M and H.K.).
Analysis ofDNA content in cancer cells
A cellular DNA analysis was performed on paraffin sections
cut 10 micrometers thick. The sections were stained with
Feulgen stain, and examined using a microspectrophotometer
(MPV 3, Leitz, FRG) by the two-wavelength method (Patau,
1952). Data processing was carried out using a personal
computer (HP-85, Hewlett-Packard, Palo Alto, Calif., USA).
In each section, the mean DNA value of 25 stromal lym-
phocytes was used as a control of the normal diploid comple-
ment (2c). The relative DNA content as compared with the
2c value was determined in 100 cancer cells in each lesion as
previously described (Backing et al., 1985; Matsuura et al.,
1986; Korenaga et al., 1990). The DNA distribution patterns
were then classified into four types, according to the degree
of the peak and dispersion on the DNA histogram, as fol-
lows (Matsuura et al., 1986): type I, a prominent peak in the
2c region with a dispersion to the 4c region; type II, a
relative high peak in the 2c-3c regions with a dispersion
limited up to the 6c region; type III, a low peak beyond the
3c region with less than 20% of the cells beyond the 6c
region; and type IV, multiple peaks with a broad dispersion
and more than 20% of cells beyond the 6c region (Figure 1).
We confirmed that there were no inter-observer errors. In
the current study, there were no cases with type I, 26 with
type II, 39 with type III, and 26 with type IV DNA distribu-
tion patterns.
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Figure 1 Representative histogram of the DNA distribution pat-
tern.
Analysis ofAgNOR number
Both the staining and counting of AgNORs were performed
as previously described (Morita et al., 1991). The paraffin
embedded sections were cut 4 micrometers thick and the
AgNOR staining solution was obtained with I volume of 2%
gelatin in 1% formic acid to two volumes of 50% aqueous
silver nitrate. The AgNOR staining solution was poured over
the dewaxed and hydrated sections for 1 h at room
temperature in the dark. The silver colloid was then washed
off with deionised water and the sections were then dehyd-
rated through graded ethanol to xylene.
A magnification of x 1000 was used for counting the
AgNOR. At least 100 cells from each tumour were examined
while choosing the field at random and avoiding any non-
cancerous areas detected with hematoxylin eosin staining. In
each case, the number of AgNOR dots per nucleus (AgNOR
number) was calculated. There were no statistical differences
between the AgNOR numbers obtained by counting 100
nuclei and those obtained by 1000 nuclei in a pilot study.
No statistical inter-observer differences were recognised in
the AgNOR number. Since the average of the AgNOR
number was nearly five in cesophageal carcinoma (Morita et
al., 1991), we divided the patients into three groups accord-
ing to the AgNOR number; low range (AgNOR number
<4); medium range (4 (AgNOR number <6); high range
(6<AgNOR number). In this study, there were 28 with a
low range, 41 with a medium range, and 22 with a high range
AgNOR number.
Statistical analysis
The correlation between the mean DNA content and the
AgNOR number was then analysed by a linear regression
analysis, and the relationship between the range of the
AgNOR number and the DNA distribution pattern was
evaluated, using the chi square test. The DNA distribution
pattern and the range of the AgNOR number were analysed
with regard to clinicopathological features by the chi square
test. Survival analyses were also made with the generalised
Wilcoxon analysis. Any deaths resulting from causes other
than the primary cancer were censored in the statistical
analysis.
A difference of P <0.05 was regarded as not signficant.
Results
Analysis ofthe DNA distribution pattern and range ofthe
AgNOR number with regard to clinicopathologicalfeatures and
prognosis
Among clinical features, both the DNA distribution pattern
and the AgNOR number correlated with the length of the
tumour (P<0.05), while they had no significant correlation
with the other clinical characteristics, such as sex, age, or site
of tumour (Table I). As for pathological features, the
incidence of lymph node metastasis was higher in proportion
to the degree of DNA aneuploidy and the range of the
AgNOR number (P<0.01). There was a tendency for both
the DNA ploidy and AgNOR number to be higher in the
more advanced groups in view of these features (Table II).
The DNA distribution pattern and AgNOR number
reflected the postoperative survival of the patients, as shown
in Figure 2a and 2b. The survival time ofpatients with a type
II DNA distribution pattern was significantly longer as com-
pared to those with type III (P<0.05) and type IV
(P<0.01). The 5 year survival rates for types II, III, and IV
were 53.2, 26.7, and 10.3%, respectively (Figure 2a). In terms
of AgNOR number, the cases with a high range AgNOR
number had a poor prognosis with only a 13.3% 5 year
Table I DNA distribution pattern, range of AgNOR number, and clinical features
No. of DNA distribution pattern Range ofAgNOR number
Clinicalfeatures cases II III IV P Low Medium High P
All 91 26 39 26 28 41 22
Sex
Male 77 21 34 22 23 36 18
Female 14 5 5 4 NS 5 5 4 NS
Age
30-49 6 1 1 4 2 1 3
50-69 65 20 27 18 21 30 14
70- 20 5 11 4 NS 5 10 5 NS
Site of tumour
Upper esophagus 12 6 3 3 7 1 4
Midesophagus 61 14 30 17 14 35 12
Lower csophagus 18 6 6 6 NS 7 5 6 NS
Length of tumour (cm)
< 5.0 29 13 12 4 14 13 2
> 5.0 62 13 27 22 <0.05 14 28 20 <0.05
P: based on chi-square test. NS: not significant.
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Table II DNA distribution pattern, range of AgNOR number, and pathological features
Pathological No. of DNA distribution pattern Range ofAgNOR number
features cases II III IV P Low Medium High P
Differentiation of SCC
Well 23 6 11 6 8 10 5
Moderately 43 11 19 13 9 23 11
Poorly 25 9 9 7 NS 11 8 6 NS
Depth of penetration
No invasion to the 34 13 14 7 16 13 5
adventitia
Invasion to the 31 8 16 7 7 17 7
adventitia
Invasion into the 26 5 9 12 NS 5 11 10 NS
neighbouring area
Lymph node metastasis
Negative 54 23 21 10 24 20 10
Positive 37 3 18 16 <0.01 4 21 12 <0.01
Lymphatic invasion
Negative 49 16 20 13 18 23 8
Positive 42 10 19 13 NS 10 18 14 NS
Vessel invasion
Negative 73 21 31 21 22 34 17
Positive 18 5 8 5 NS 6 7 5 NS
P: based on chi-square test. SSC: squamous cell carcinoma: NS: not significant.
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Figure 2 Survival of91 patients after csophagectomy. a, survival curves according to DNA distribution pattern. The survival time of patients with type II is significantly longer than both those with type III (P<0.05) and type IV (P<0.01). b, survival curves according to AgNOR number. The survival time of patients with a high range AgNOR number is significantly shorter than both those with a low range AgNOR number (P<0.01) and those with a medium range AgNOR number (P<0.05).DNA AND AGNOR OF (ESOPHAGEAL CARCINOMA 483
survival rate, which was statistically different as compared to
a rate of 44.8% in the low range (P<0.01) and a rate of
32.5% in the medium range (P<0.05) (Figure 2b).
Relation between the DNA analysis and AgNOR number
Figure 3 shows the results of a linear regression analysis of
the mean DNA content and the AgNOR number in 91 cases.
There was a significant linear dependence between them
(r = 0.615, P<0.001). The AgNOR number was also larger
in proportion to the mean DNA content.
Concerning the range of the AgNOR number with regard
to the DNA distribution pattern, a significant correlation was
observed between these two parameters (P<0.01) (Table
III). A lower AgNOR number correlated with a diploid
pattern, whereas a higher AgNOR number correlated with
high ploidy. Among the 28 cases with a low range AgNOR
number, 23 cases were classified as type II and only one as
type IV. On the other hand, 17 of the 22 cases with a high
range AgNOR number were determined to be type IV and
there were no cases of type II. Among the 41 cases with a
medium range AgNOR number group, 3, 30, and eight cases
were classified as types II, III, and IV, respectively.
Table III DNA distribution pattern and range ofAgNOR number
DNA distribution pattern
II III IV
AgNOR number n = 26 n = 39 n = 26 Total
Low range 23 4 1 28
Medium range 3 30 8 41
High range 0 5 17 22
P<0.01 by chi-square test.
Postoperative survival and combined the DNA distribution
pattern andAgNOR number
We separated the 91 cases into three groups from the view
point of the combined DNA distribution pattern and
AgNOR number. Group 1 comprised cases with both a type
II DNA distribution pattern and a low range AgNOR number; group 3 comprised both type IV DNA distribution
and a high range AgNOR number; group 2 included the
remaining cases. The survival rates at 1, 3, and 5 years were
91.3, 68.9, and 55.2% in group 1 and 66.7, 34.6, and 28.0%
in group 2, respectively (P<0.01). The survival in group 3
was significantly poorer as compared to group 1 (P<0.001) and group 2 (P<0.05). The one year survival rate was only 49.9% and there were no cases who survived over 4 years
among the 17 cases in group 3 (Figure 4).
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The biologic role of the AgNOR number is still controversial *. in comparative studies between AgNOR and DNA content
obtained by flow cytometry. The AgNOR number was earlier
shown to reflect proliferative status rather than ploidy (Crocker et al., 1988), whereas a more recent study revealed
that AgNOR number correlated best with ploidy (Mourad et
al., 1992). This study documented the existence of a
signficant correlation between the cellular DNA content and
AgNOR number, both ofwhich are currently accepted as the
prognostic indicators of various malignancies (Korenaga et
6C al., 1988; Blondal et al., 1981; Egan et al., 1988b; Ruschoff et al., 1990) including cesophageal carcinoma (Matsuura et al., 1986; Morita et al., 1991).
The NORs have been biochemically proven to be loops of A content in the DNA (rDNA) encoding rRNA (Fakan & Hernandez-Verdan, =91, r = 0.615, 1986) and AgNOR is considered to be a marker of rDNA
transcription activity and/or of the rDNA transcriptional
potential (Burch, 1984; Dimova, 1987). The number of
acrocentric chromosomes with AgNORs has been proven to
be positively related to the number of chromosomes per cell
(Miller et al., 1978). In aneuploid cells, the modal number of chromosomes, including acrocentrics would have to be higher than in diploid cells. Thus, a higher AgNOR number for
aneuploid cells would be expected.
Group 1 (n = 23) Histopathological studies revealed that the AgNOR number was closely related to the mitosis-karyorrherix index (Egan et al., 1988a) and immunohistochemical staining with
Ki-67 (Kakeji et al., 1991; Hall et al., 1988) and Group 2 (n = 51) Bromodeoxyuridine (Tanaka et al., 1989), all of which reflect the cellular kinetics and mitotic activity of malignant
tumours. These findings suggest that the AgNOR number
should reflect the proliferative activity of the cancer cells. On
the other hand, studies of the breast lesions have suggested 4 5 that the AgNOR number was, at least partially, related to
ploidy (Giri et al., 1989; Mourad et al., 1992). This problem
was also carefully investigated by a study, using trophoblastic nbined group of tissues (Suresh et al., 1990). In this study, the AgNOR uv range AgNOR number was compared between partial moles that were
both a type IV usually aneuploid with a low proliferative activity and com- botha typber plete moles that were usually diploid with a high proliferative
differences wer, index. The AgNOR number ofpartial moles was found to be
etween groups I significantly higher than that of complete moles. Thus, in 3 (P<0.05). non-neoplastic trophoblastic tissues, the AgNOR number
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was proven to be a reflection of ploidy rather than of cell
proliferation.
In clinical cesophageal carcinoma, high-ploidy tumours grow
more rapidly than low-ploidy tumours, and the duration
from curative esophagectomy to recurrence decreases in pro-
portion to the degree of DNA aneuploidy (Matsuura et al.,
1991). Significant correlations have been shown betwen the
mitotic rates and DNA variants, such as with the peak value,
the mean value, and the frequency of cells with values ex-
ceeding tetroploid or hexaploid chromosome complement, in
gastric carcinoma (Korenaga et al., 1990). The DNA dist-
ribution patterns adopted in our study were based on the
peak values and the frequency of values exceeding the tetra-
ploid chromsome complement. These findings suggest that
the DNA distribution pattern and the mean DNA content of
cesophageal carcinoma, both of which directly reflect the
ploidy, may indirectly reflect the proliferative status of the
tumour: In clinical oesophageal carcinoma, ploidy may
indirectly reflect the proliferative activity. This may be true of
other clinical cancers although ploidy and cell proliferation
are, in general, considered to be independent indicators, as
shown by trophoblastic tissues. In this respect, both the close
relationship between the AgNOR number and ploidy, and
that between the AgNOR number and proliferative activity
seem to be reasonable assumptions in clinical malignant
lesions, while the AgNOR number has been proven to reflect
the ploidy rather than proliferative activity in the ideal model
like trophoblast (Suresh et al., 1990).
In patients with carcinoma of the cesophagus, the outcome
of treatment is poor. A large number of cases experience
recurrence rapidly after operation, even if a curative oper-
ation is attempted (Matsuura et al., 1991). Therefore, it is
important to predict malignant potentiality of tumours
preoperatively and to treat high-malignant cases with radical
surgery as well as with both pre- and postoperative
treatments, including radiotherapy and chemotherapy. In
biopsy specimens taken by endoscopy, the sample size is
small and many cells other than cancer cells are often
included. Accurate identification of cancer cells is essential
since only cancer cells may be used for analysis. It is possible
to use only cancer cells for analysis both in the cyto-
photometric DNA analysis and in the measuring of the
AgNOR number, since these methods permit distinction of
all kinds of cells in the specimen. Furthermore, studies com-
paring cytophotometry and flow cytometry, in which DNA
content was measured in a large number of cells in the same
lesions have shown the close correlations in the ploidy (coin-
cidence rate = 89%) (Yoshida et al., 1988) and in the modal
DNA values (r = 0.83) (Strang et al., 1985).
Our previous studies demonstrated that DNA content and
AgNOR number were the most important predictors in the
prognosis ofpatients with carcinoma of the esophagus (Mat-
suura et al., 1986; Sugimachi et al., 1988; Morita et al.,
1991). In the current study, the combined detection of the
DNA distribution pattern and AgNOR number was shown
to predict the patient's prognosis more accurately than only a
DNA analysis or AgNOR number used alone. No patients
with a type IV DNA distribution pattern and a high range
AgNOR number survived longer than 4 years after oper-
ation, whereas patients with a type II DNA distribution
pattern and a low AgNOR number showed a good pos-
toperative course with a 5 year survival rate of 55.2%. The
above data indicate that the combination of DNA ploidy and
AgNOR number will be extremely useful, especially for the
detection of high-malignant groups among cases with
oesophageal carcinoma. Furthermore, these two methods are
simple to carry out and they can be applied to routinely
processed paraffin embedded sections, event if they are
minute as biopsy specimens.
In conclusion, the preoperative characterisation with either
DNA content or AgNOR, using biopsy specimens, is con-
sidered to be of great use in predicting the prognosis of cases
with cesophageal carcinoma and the combination of these two
methods should provide more precise information in the
detection of high-malignant cases.
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